David S. Grayzel - Director at Q32 Bio Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
QTTB on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David S. Grayzel since 11/23/2023

Holdings reported by David S. Grayzel for Q32 Bio Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 864K $494K $0.57 Mar 25, 2024 By Atlas Venture Fund X, L.P.
Common Stock 725K $414K $0.57 Mar 25, 2024 By Atlas Venture Opportunity Fund II, L.P.
Common Stock 503K $287K $0.57 Mar 25, 2024 By Atlas Venture Opportunity Fund I, L.P.
Stock Option (Right to Buy) 2.57K $34.5K $13.42 Apr 1, 2024 Direct Common Stock

Transactions reported by David S. Grayzel for Q32 Bio Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.